Center for Investigation and Research in Sleep, University Hospital of Lausanne, Lausanne, Switzerland.
Department of Internal Medicine and University Hospital of Lausanne, Lausanne, Switzerland.
High Alt Med Biol. 2022 Jun;23(2):165-172. doi: 10.1089/ham.2022.0012.
Heiniger, Grégory, Simon Walbaum, Claudio Sartori, Alban Lovis, Marco Sazzini, Andrew Wellman, and Raphael Heinzer. Altitude-Induced Sleep Apnea Is Highly Dependent on Ethnic Background (Sherpa Vs. Tamang). . 23:165-172, 2022. High altitude-induced hypocapnic alkalosis generates central sleep apnea (CSA). In Nepal, two ethnic groups live at medium-to-high altitude: Tamangs originate from low-altitude Tibeto-Burman populations, whereas Sherpas descend from high-altitude Tibetans. To compare apnea severity at low and high altitude between Sherpas and Tamangs. Polygraphy recordings, including airflow and oxygen saturation, were performed in Nepal at "low" (2,030 m) and "high" (4,380 m) altitudes. Resting ventilation () and mixed-exhaled CO (FCO) were also measured at the same altitudes. Differences in apnea-hypopnea index (AHI), oxygen desaturation index (ODI), and % of nocturnal periodic breathing (NPB) at the two altitudes were compared between ethnicities. Twenty Sherpas and 20 Tamangs were included (males, median [interquartile range] age: 24.5 [21.5-27.8] years vs. 26.0 [21.5-39.8] years, body mass index: 23.9 [22.1-26.1] kg/m vs. 25.21 [20.6-27.6] kg/m). Compared with Tamangs, Sherpas showed a lower increase in AHI (+7.5 [2.6-17.2]/h vs. +31.5 [18.2-57.3]/h, < 0.001), ODI (+13.8 [5.5-28.2]/h vs. +42.0 [22.6-77.6]/h, < 0.001), and NPB proportion (+0.9 [0-3.5]% vs. +12.8 [3.1-27.4]%, < 0.001) from low to high altitude. Resting was higher in Sherpas versus Tamangs at both low (8.45 [6.89-10.70] l/min vs. 6.3 [4.9-8.3] l/min, = 0.005) and high (9.7 [8.5-11] l/min vs. 8.74 [7.39-9.73] l/min, = 0.020) altitudes, whereas the mean ± standard deviation FCO decrease between low and high altitude was greater in Tamangs versus Sherpas (-0.50% ± 0.44% vs. -0.80% ± 0.33%, < 0.023). Overall, altitude-adapted Sherpas showed a 3.2-times smaller increase in sleep-disordered breathing between low and high altitude compared with Tamangs, and higher ventilation and a smaller drop in FCO at high altitude. These data suggest that genetic differences in breathing control can be protective against CSA.
海尼格、格雷戈里、西蒙·瓦尔鲍姆、克劳迪奥·萨托里、阿尔班·洛维斯、马尔科·萨齐尼、安德鲁·韦尔曼和拉斐尔·海尼格。海拔引起的睡眠呼吸暂停高度依赖于种族背景(夏尔巴人与塔芒人)。23:165-172,2022 年。高海拔引起的低碳酸血症性碱中毒会引起中枢性睡眠呼吸暂停(CSA)。在尼泊尔,有两个种族生活在中高海拔地区:塔芒人起源于低海拔的藏缅人群,而夏尔巴人则来自高海拔的西藏。比较夏尔巴人和塔芒人在低海拔和高海拔时的睡眠呼吸暂停严重程度。在尼泊尔的“低”(2030 米)和“高”(4380 米)海拔进行了多导睡眠图记录,包括气流和氧饱和度。还在相同海拔测量了静息通气量()和混合呼出的 CO(FCO)。比较了两种族在两个海拔高度的睡眠呼吸暂停-低通气指数(AHI)、氧减饱和指数(ODI)和夜间周期性呼吸(NPB)的百分比差异。共纳入 20 名夏尔巴人和 20 名塔芒人(男性,中位数[四分位数范围]年龄:24.5[21.5-27.8]岁 vs. 26.0[21.5-39.8]岁,体重指数:23.9[22.1-26.1]kg/m vs. 25.21[20.6-27.6]kg/m)。与塔芒人相比,夏尔巴人的 AHI 增加幅度较小(+7.5[2.6-17.2]/h vs. +31.5[18.2-57.3]/h, < 0.001)、ODI 增加幅度较小(+13.8[5.5-28.2]/h vs. +42.0[22.6-77.6]/h, < 0.001)和 NPB 比例增加幅度较小(+0.9[0-3.5]% vs. +12.8[3.1-27.4]%, < 0.001)从低海拔到高海拔。与塔芒人相比,夏尔巴人在低(8.45[6.89-10.70]l/min vs. 6.3[4.9-8.3]l/min, = 0.005)和高(9.7[8.5-11]l/min vs. 8.74[7.39-9.73]l/min, = 0.020)海拔时的静息通气量更高,而塔芒人与夏尔巴人之间的 FCO 下降幅度在低海拔和高海拔之间的差异更大(-0.50% ± 0.44% vs. -0.80% ± 0.33%, < 0.023)。总的来说,与塔芒人相比,适应高海拔的夏尔巴人在低海拔和高海拔之间的睡眠呼吸障碍增加幅度小 3.2 倍,并且在高海拔时通气量更高,FCO 下降幅度更小。这些数据表明,呼吸控制方面的遗传差异可能对 CSA 具有保护作用。